To examine the role of community‐based nursing interventions in improving outcomes for community‐dwelling individuals exhibiting risk factors of cardiovascular disease (CVD).. To read the full article, log in using your MPFT NHS OpenAthens details.
To assess randomized controlled trials evaluating the impact of nurse practitioner‐led cardiovascular care.. To read the full article, log in using your MPFT NHS OpenAthens details.
To evaluate the effects of once‐daily valbenazine (40 or 80 mg/day) in older and younger adults with tardive dyskinesia (TD).. To read the full article, log in using your MPFT NHS OpenAthens details.
Prescribers should be alert for neuropsychiatric reactions in patients taking montelukast and carefully consider the benefits and risks of continuing treatment if they occur.
This guidance is for commissioners, public health directors and others involved in the local planning and provision of services and interventions that support people with cardiovascular disease (CVD) conditions.
Public Health England (PHE) collates and analyses available CVD data and produces intelligence resources to help with improving services and outcomes. This guidance supports health professionals with using these resources to make or influence decisions about local services.